This webinar will focus on outcome data evaluating CKD progression in the context of glycemic control as well as data from short versus long term studies that evaluates the impact of glycemic control on CKD progression.
.
Description of the Webinar
Historically glycemic control has not been associated with a significant slowing of CKD progression. Rather it is more closely tied to reduced risk of retinopathy and neuropathy development. More recently, very long term epidemiological studies spanning more than 25-30 years demonstrate a benefit of glycemic control on slowing nephropathy progression. These are seen largely from the DCCT/EDIC studies in Type 1 diabetes. Clearly, while glycemic control is not as substantive as blood pressure it adds benefit over the long term.
Webinar Registration:
This webinar was held on Thursday February 26, 2015 10:00 AM – 11:00 AM CST
View the webinar and take the post-webinar quiz!
About the Facilitator
 |
Dr. George Bakris is Professor at the University of Chicago Medicine where he directs the Comprehensive Hypertension Center and the Hypertension Fellowship Program as well as the Clinical Research Labs where ongoing clinical trials occur. He has more than 700 publications and book chapters and is the Editor of 18 books in the areas of hypertension and diabetic kidney disease. He currently serves as the Hypertension Editor of UpToDate and is the Editor-in-Chief of Am J Nephrology and Associate Editor of Diabetes Care. He also serves on 14 different editorial boards and is a special government employee to FDA. |
Additional Info
-
Language:
English -
Contains Audio:
Yes -
Content Type:
Webinars -
Source:
ISN -
Event:
Other events -
Year:
2015 -
Members Only:
No